Search

everythinglearnresearchcommunity

for

Search:↓

Hypothyroidism in dogs is usually caused by immune system issues or gland atrophy, affects middle-aged purebreds most, and is treatable with medication.

Erdr1 could be a new marker for diagnosing hair loss.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

The combination of laser and topical steroids is more effective for treating alopecia areata than topical steroids alone.

A young man had a rare case of hair cysts on his elbows, which was hard to diagnose and treat.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Using platelet-rich plasma with microneedling works better for acne scars than microneedling with water.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Cats with atopic dermatitis often have severe, year-round itching and respond well to certain treatments.

Platelet-rich plasma treatment can significantly increase hair count and density in men with pattern baldness, and these improvements can last up to 3 months.

Stopping minoxidil treatment resumes balding; continuous use needed for results.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.